The detection of ADAM17 in serum has so far only been described for inflammatory diseases such as rheumatoid arthritis or endotoxic shock syndrome in sepsis, but not in connection with a malignant gynecological disease such as ovarian cancer [19,20]. This evidence concerns the gene ADAM17 and ovarian cancer.